Gastrointestinal drugs

Side Effects of Drugs Annual

Volumn 27, Issue , 2004, Pages 362-372

  de Silva, H J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750874997     PISSN: 03786080     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0378-6080(04)80043-6     Document Type: Article

References (68)

1. [Spanish] Caro L Curi LA Giglio NR Mezzotero O Cinitapride versus cisapride in the treatment of non-ulcer dyspepsia Prensa Med Argent 89 2002 95 101
2. Franzese A Borrelli O Corrado G Rea P Di Nardo G Grandinetti AL Domperidone is more effective than cisapride in children with diabetic gastroparesis Aliment Pharmacol Ther 16 2002 951 957
3. Pehlivanov N Sarosiek I Whitman R Olyaee M McCallum R Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and noctural gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study Aliment Pharmacol Ther 16 2002 743 747
4. Finizia C Lundell L Cange L Ruth M The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastroeosophageal reflux disease Eur J Gastroenterol Hepatol 14 2002 9 14
5. c interval in infants receiving cisapride J Perinatol 22 2002 144 148
6. Vergin H Fisch U Mahr G Winterhalter B Analysis of formulation and food effect on the absorption of metoclopramide Int J Clin Pharmacol Ther 40 2002 169 174
7. Lifshitz M Gavrilov V Adverse reactions to metoclopramide in young children: a 6-year retrospective study and review of the literature J Pharm Technol 18 2002 125 127
8. [Dutch] Hoogendam A Hofmeijer J Frijns CJM Heeringa M Severe parkinsonism as a consequence of metoclopramide use in a patient with polypharmacy Ned Tijdschr Geneeskd 146 2002 175 177
9. Van der Kleij FGH De Vries PAM Stassen PM Sprenger HG Gans ROB Acute dystonia due to metoclopramide: Increased risk in AIDS Arch Intern Med 162 2002 358 359
10. Lu M-L Pan J-J Teng H-W Su K-P Shen WW Gonzalez L Demers D Metoclopramide-induced supersensitivity psychosis Ann Pharmacother 36 2002 1387 1390
11. Raynov J Danon S Valerianova Z Control of acute emesis in repeated courses of moderately emetogenic chemotherapy J BUON 7 2002 57 60
12. Jokela R Koivuranta M Kangas-Saarela T Purhonen S Alahuhta S Oral ondansetron, tropisetron or metoclopramide to prevent post-operative nausea and vomiting: a comparison in high-risk patients undergoing thyroid or parathyroid surgery Acta Anaesthesiol Scand 46 2002 519 524
13. Ozmen S Yavuz L Ceylan BG Tarhan O Aydin C Comparison of granisetron with granisetron plus droperidol combination prophylaxis in postoperative nausea and vomiting after laparoscopic cholecystectomy J Int Med Res 30 2002 520 524
14. Feng FY Zhang P He YJ Li YH Zhou MZ Cheng G Chen Y Kikkawa T Yamamoto M Oral formulations of the selective serotonin 3 antagonists ramosetron (intraoral disintegrator formulation) and granisetron hydrochloride (standard tablet) in treating acute chemotherapy-induced emesis, nausea and anorexia: a multicenter, randomized, single-blind, crossover, comparison study Curr Ther Res Clin Exp 63 2002 725 735
15. Kang YK Park YH Rayoo BY Bang YJ Cho KS Shin DB Kim HC Lee KH Park YS Lee KS Heo DS Kim SY Cho EK Lim HY Kim WK Lee JA Kim TY Lee JC Yoon HJ Kim NK Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron J Int Med Res 30 2002 220 229
16. Ruscin JM Page RL II Valuck RJ Vitamin B12 deficiency associated with histamine 2-receptor antagonists and a proton pump inhibitor Ann Pharmacother 36 2002 812 816
17. Kawano S Murata H Tsuji S Kubo M Tatsuta M Iishi H Kanda T Sato T Yoshihara H Masuda E Noguchi M Kashio S Ikeda M Kaneko A Randomized comparative study of omeprazole and famotidine in reflux esophagitis J Gastroenterol Hepatol 17 2002 955 959
18. Tutuian R Katz PO Ahmed F Korn S Castell DO Over-the-counter H2-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors Aliment Pharmacol Ther 16 2002 473 477
19. Itokazu GS Fischer JH Manitpisitkul P Hariharan R Danziger LH Lack of effect of nizatidine-induced elevation of gastric pH on the oral biovailability of dapsone in healthy volunteers Pharmacothery 22 2002 1420 1425
20. Liberopoulos EN Nonni AB Tsianos EV Elisaf MS Possible ranitidine induced jaundice Ann Pharmacother 36 2002 172
21. Orenstein SR Blumer JL Faessel HM McGuire JA Fung K Li Buk Lavine JE Grunow JE Treem WR Ciociola AA Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effect in children with symptoms of gastro-oesophageal reflux Aliment Pharmacol Ther 16 2002 899 907
22. Rohss K Hasselgren G Hedenstrom H Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease Dig Dis Sci 47 2002 954 958
23. Mulder CJJ Westerveld BD Smit JM Oudkerk Pool M Otten MH Tan TG Van Milligen de Wit AWM De Groot GH A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System, (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicenter trial Eur J Gastroenterol Hepatol 14 2002 649 656
24. Johnson M Guilford S Libretto SE Patients have treatment preferences: a multicenter, double-blind, crossover study comparing rabeprazole and omeprazole Curr Med Res Opin 18 2002 303 310
25. Holtmann G Bytzer P Metz M Loeffler V Blum AL A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease Aliment Pharmacol Ther 16 2002 479 485
26. Kale-Pradhan PB Landry HK Sypula WT Mena R Perreault MM Esomeprazole for acid peptic disorders Ann Pharmacother 36 2002 655 663
27. Graham DY Agrawal NM Campbell DR Haber MM Collis C Lukasik N Huang B Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results, of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole Arch Intern Med 162 2002 169 175
28. Esaki M Aoyagi K Matsumoto T Kuwano Y Shimizu M Fujishima M Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans Eur J Gastroenterol Hepatol 14 2002 365 369
29. Khatib MA Rahim O Kania R Molloy P Iron deficiency anemia-induced by long term ingestion of omeprazole Dig Dis Sci 47 2002 2596 2597
30. Odeh M Lurie M Oliven A Cutaneous leucocytoclastic vasculitis associated with omeprazole Postgrad Med J 78 2002 114 115
31. Pique JM Feu F De Prada G Rohss K Hasselgren G Pharmacokinetics of omeprazole given by continuous intravenous infusion to patients with varying degrees of hepatic dysfunction Clin Pharmacokinet 41 2002 999 1004
32. Meneghelli UG Boaventura S Morraes-Filho JPP Leitao O Ferrari AP Jr Almeida JR Magalhaes AFN Castro LP Haddad MT Tolentino M Jorge JL Silva E Maguilnik I Fischer R Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate Dis Esophagus 15 2002 50 56
33. Kovacs TOG Wilcox CM Devault K Miska D Bochenek W Avner D Comparison of the efficacy of pantoprazole vs nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study Aliment Pharmacol Ther 16 2002 2043 2052
34. Talley NJ Moore MG Sprogis A Katelaris P Randomized controlled trial of pantoprazole vs ranitidine for the treatment of uninvestigated hearbburn in primary care Med J Aust 177 2002 423 427
35. Fujita R Takahashi H Iwashige M Kamiyama T Hara H Koyoma T Clinical evaluation of proton pump inhibitor, rabeprazole—special surveillance in patients of advanced age with peptic ulcer diseases Jpn Pharmacol Ther 30 2002 539 549
36. Kinoshita Y Hirayama M Hamada S Yoshida T Ishii N Nakata R Chishima J Handa Y Saito K Takayama T Tatsumi S Iishi H Kohll Y Fujita S Tanaka H Ookuchi S Suzuki S Koyama T Yoshida Y Kabemura T Matsumoto K Efficacy of rabeprazole in patients with reflux esophagitis: a single-center, open-label, practice-based, postmarketing surveillance investigation Curr Ther Res Clin Exp 63 2002 810 820
37. Robinson M Fitzgerald S Hegedus R Murthy A Jokubaitis L Onset of symptom relief with rabeprazole: a community-based, open-labed assessment of patients with erosive oesophagitis Aliment Pharmacol Ther 16 2002 445 454
38. De Freitas JA Effectiveness and tolerability of rabeprazole 20 mg as once-daily monotherapy in treatment of erosive or ulcerative gastro-oesophageal disease Clin Drug Invest 22 2002 279 289
39. Gaig P Garcia-Ortega P Enrique E Papo M Quer JC Richard C Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study Allergol Immunopathol 30 2002 255 258
40. Tsukada K Miyazaki T Katoh H Masuda N Ojima H Fukai Y Nakajima M Manda R Fukuchi M Kawano H Tsukada O Seven day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients Scand J Gastroenterol 37 2002 1265 1268
41. Prado D A multinational comparison of racecadotril and loperamide in the treatment of acute watery diarrhoe in adults Scand J Gastroenterol 37 2002 656 661
42. Tuohy KM Ziemer CJ Klinder A Knobel Y Pool-Zobel BL Gibson GR A human volunteer study to determine the prebiotic effects, of lactulose powder on human colonic microbiota Microb Ecol Health Dis 14 2002 165 173
43. Reddy DN Rao GV Sriram PVJ Efficacy and safety of oral sodium phosphate versus polyethylene glycol solution for bowel preparation for colonoscopy Indian J Gastroenterol 21 2002 219 221
44. Rex DK Chasen R Pochapin MB Safety and efficacy of two reduced dosing regimens of sodium phosphate tablets for preparation prior to colonoscopy Aliment Pharmacol Ther 16 2002 937 944
45. Mackey AC Shaffer D Prizant R Seizure associated with the use of Visicol for colonoscopy New Engl J Med 346 2002 2095
46. Ransford RAJ Langman MJS Sulphasalazine and mesalazine: serious adverse reactions reevaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines Gut 51 2002 536 539
47. Mahmud N O'toole D O'Hare N Freyne PJ Weir DG Keileher D Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis Aliment Pharmacol Ther 16 2002 207 215
48. Dewit O Vanheuverzwyn R Desager JP Horsmans Y Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease Aliment Pharmacol Ther 16 2002 79 85
49. Schroeder KW Role of mesalazine in acute and long term treatment of ulcerative colitis and its complications Scand J Gastroenterol Suppl 37 2002 42 47
50. Malchow H Gertz B A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema, in patients with active distal ulcerative colitis Aliment Pharmacol Ther 16 2002 415 423
51. Oxentenko AS Loftus EV Oh JK Danielson GK Mangan TF Constrictive pericarditis in chronic ulcerative colitis J Clin Gastroenterol 34 2002 247 251
52. Yano S Kobayashi K Kato K Nishimura K A limited form of Wegener's granulomatosis with bronchiolitis obliterans organizing pneumonitis-like variant in an ulcerative colitis patient Intern Med 41 2002 1013 1015
53. Iofel E Chawla A Daum F Markowitz J Mesalamine intolerance mimics symptoms of active inflammatory bowel disease J Pediatr Gastroenterol Nutr 34 2002 73 76
54. Frandsen NE Saugmann S Marcussen N Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease Nephron 92 2002 200 202
55. Ohya M Otani H Kimura K Kodama N Minami Y Liang X-M Maeshima Yamada Y Mune M Yakawa S Interstitial nephritis induced by mesalazine Jpn J Nephrol 44 2002 414 419
56. [French] Laboudi A Makdassi R Cordonnier C Fournier A Choukroun G Chronic interstitial nephritis induced by mesalazine Nephrologie 23 2002 343 347
57. Beaulieu S Rocher P Hillion D Tennenbaum R Vitte R-L Eugene C Acute tubular necrosis with acute renal failure during the first month of treatment with 5-amino-salicylate (Pentasa) Gastroenterol Clin Biol 26 2002 412 414
58. Nguyen-Khac E Le Baron F Thevenot T Tiry-Lescut C Tiry F Angioedema in Crohn's disease possibly due to mesalazine Gastroenterol Clin Biol 26 2002 535 536
59. Parry SD Barbatzas C Peel ET Barton JR Sulphasalazine and lung toxicity Eur Respir J 19 2002 756 764
60. [German] Schmidt WA Wierth S Milleck D Droste U Gromnica-Ihle E Sulfasalazine in ankylosing spondylitis: a prospective, randomized, double-blind placebo-controlled study and comparison with other controlled studies Z Rheumatol 61 2002 159 167
61. Jiang L Zhao N Ni L Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs Zhonghua Liu Xing Bing Xue Za Zhi 23 2002 213 217
62. [German] Schiemann U Kellner H Gastrointestinal side effects in the therapy of rheumatologi diseases Z Gastroenterol 40 2002 937 943
63. Savino F Brondello C Cresi F Oggero R Silvestro L Cimetropium bromide in the treatment of crisis in infantile colic J Pediatr Gastroenterol Nutr 34 2002 417 419
64. Mohamed AE Ghandour ZM Al-Karawi MA Spasmocanulase in irritable bowel syndrome Saudi Med J 23 2002 1074 1077
65. George R Stevens A Berkenbosch JW Turpin J Tobias J Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients South Med J 95 2002 1276 1279
66. Buyukgebiz B Arslan N Ozturk Y Soyal C Lebe B Drug reaction, to ursodeoxycholic acid: lichenoid drug eruption in an infant using ursedeoxycolic acid for neonatal hepatitis J Pediatr Gastroenterol Nutr 35 2002 384 386
67. Huo T-L Huang Y-H Wu J-C Lee P-C Chang F-Y Lee S-D Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapy Scand J Gastroenterol 37 2002 350 355
68. [Turkish] Memis D Tukenmez B Pamukcu Z Hypernatremia due to hypertonic solution usage during cyst hydatid surgery Turk Anesteziyol Reanim 30 2002 330 333